(Q37873408)

24 August 2017

1 reference

title

The unique characteristics and management of patients over 60 years of age with classic Hodgkin lymphoma (English)

1 reference

24 August 2017

Teresa V Halbsguth

1

1 reference

24 August 2017

Boris Böll

series ordinal

2

1 reference

24 August 2017

Peter Borchmann

series ordinal

3

1 reference

24 August 2017

Volker Diehl

series ordinal

4

1 reference

24 August 2017

publication date

1 September 2011

1 reference

Current hematologic malignancy reports

24 August 2017

published in

1 reference

24 August 2017

volume

6

1 reference

24 August 2017

issue

3

1 reference

24 August 2017

page(s)

164-171

1 reference

Standard and increased-dose BEACOPP chemotherapy compared with COPP-ABVD for advanced Hodgkin's disease

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11899-011-0089-7

Stanford V and radiotherapy for locally extensive and advanced Hodgkin's disease: mature results of a prospective clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-011-0089-7

ChlVPP/EVA hybrid versus the weekly VAPEC-B regimen for previously untreated Hodgkin's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-011-0089-7

Hodgkin's disease in the elderly: improved treatment outcome with a doxorubicin-containing regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-011-0089-7

Hodgkin's disease in the elderly: current status and future directions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-011-0089-7

Hodgkin's disease: a population-adjusted clinical epidemiology study (PACE) of management at presentation. Northern Region Lymphoma Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-011-0089-7

Impact of tumor Epstein-Barr virus status on presenting features and outcome in age-defined subgroups of patients with classic Hodgkin lymphoma: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-011-0089-7

Latent Epstein-Barr virus infection of tumor cells in classical Hodgkin's lymphoma predicts adverse outcome in older adult patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-011-0089-7

VEPEMB in elderly Hodgkin's lymphoma patients. Results from an Intergruppo Italiano Linfomi (IIL) study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-011-0089-7

Use of comprehensive geriatric assessment in older cancer patients: recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-011-0089-7

Hodgkin's disease in elderly patients (> or =60): clinical outcome and treatment strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-011-0089-7

A prospectively randomized trial carried out by the German Hodgkin Study Group (GHSG) for elderly patients with advanced Hodgkin's disease comparing BEACOPP baseline and COPP-ABVD (study HD9elderly).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-011-0089-7

Patients above Sixty Years Lymphoma Treated with a New Strategy of Age with Hodgkin's

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-011-0089-7

Treatment of elderly Hodgkin's lymphoma patients with a novel 5-drug regimen (ODBEP): a phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-011-0089-7

Classical Hodgkin's lymphoma in adults: guidelines of the Italian Society of Hematology, the Italian Society of Experimental Hematology, and the Italian Group for Bone Marrow Transplantation on initial work-up, management, and follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-011-0089-7

EORTC Cancer in the Elderly Task Force guidelines for the use of colony-stimulating factors in elderly patients with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-011-0089-7

CHOP compared with CHOP plus granulocyte colony-stimulating factor in elderly patients with aggressive non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-011-0089-7

Impact of granulocyte colony-stimulating factor (CSF) and granulocyte-macrophage CSF in patients with malignant lymphoma: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-011-0089-7

Reduced Treatment Intensity in Patients with Early-Stage Hodgkin's Lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-011-0089-7

Phase 2 study of BACOPP (bleomycin, adriamycin, cyclophosphamide, vincristine, procarbazine, and prednisone) in older patients with Hodgkin lymphoma: a report from the German Hodgkin Study Group (GHSG).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-011-0089-7

Positron emission tomography has a high negative predictive value for progression or early relapse for patients with residual disease after first-line chemotherapy in advanced-stage Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-011-0089-7

GEMOX-R regimen is a highly effective salvage regimen in patients with refractory/relapsing diffuse large-cell lymphoma: a phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-011-0089-7

An effective oral combination in advanced relapsed Hodgkin's disease prednisolone, etoposide, chlorambucil and CCNU.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-011-0089-7

The role of an all-oral chemotherapy containing lomustine (CCNU) in advanced,fs progressive Hodgkin lymphoma: a patient-friendly palliative option which can result in long-term disease control

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-011-0089-7

Trofosfamide as salvage therapy for anaplastic large cell lymphoma relapsing after high-dose chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-011-0089-7

Trofosfamide in the palliative treatment of cancer: a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-011-0089-7

Cancer Incidence in Five Continents. Comparability and quality of data

21 January 2018

1 reference

12 December 2020

Hodgkin disease in the elderly. A registry-based analysis

1 reference

12 December 2020

Hodgkin's disease in patients over sixty years old

1 reference

12 December 2020

Hodgkin's lymphoma in the elderly with special reference to type and intensity of chemotherapy in relation to prognosis

1 reference

12 December 2020

Poorer outcome of elderly patients treated with extended-field radiotherapy compared with involved-field radiotherapy after chemotherapy for Hodgkin's lymphoma: an analysis from the German Hodgkin Study Group

1 reference

12 December 2020

Hodgkin's disease in the elderly: a population-based study

1 reference

12 December 2020

The prognosis of Hodgkin's disease in older adults

1 reference

12 December 2020

Hodgkin's disease and age

1 reference

12 December 2020

An international approach to the treatment of Hodgkin's disease in the elderly: launch of the SHIELD study programme.

1 reference

12 December 2020

Standard CHOP-21 as first line therapy for elderly patients with Hodgkin's lymphoma

1 reference

12 December 2020

A web-based study concept designed to progress clinical research for 'orphan' disease areas in haematological oncology in the elderly: the SHIELD programme

1 reference

12 December 2020

Hodgkin's lymphoma in elderly patients: a comprehensive retrospective analysis from the German Hodgkin's Study Group.

1 reference

12 December 2020

Gemcitabine in the treatment of refractory Hodgkin's disease: results of a multicenter phase II study

1 reference

12 December 2020

Treatment outcome in Hodgkin's disease in patients above the age of 60: A population-based study

1 reference

12 December 2020

Results of a low aggressivity chemotherapy regimen (CVP/CEB) in elderly Hodgkin's disease patients

1 reference

12 December 2020

Hodgkin disease in patients 60 years of age or older. Histologic and clinical features of advanced-stage disease. The Cancer and Leukemia Group B

1 reference

12 December 2020

Probability of cure in elderly Hodgkin's disease patients

1 reference

12 December 2020

Hodgkin lymphoma in older patients: an uncommon disease in need of study

1 reference

12 December 2020

Prevalence of co-morbidity and its relationship to treatment among unselected patients with Hodgkin's disease and non-Hodgkin's lymphoma, 1993-1996

1 reference

12 December 2020

Efficacy of the VBM regimen in the treatment of elderly patients with Hodgkin's disease

1 reference

12 December 2020

Long-term survival in Hodgkin's disease patients

1 reference

12 December 2020

10.1007/S11899-011-0089-7

Identifiers

DOI

1 reference

24 August 2017

1 reference